Repurposing Mitragynine as Anti-SARS-CoV-2 Agent Evidenced by In Silico Predictive Approach
The outbreak of a new coronavirus strain (SARS-CoV-2) calls for the development of treatment approaches to address the disease. Therefore, an in silico study was conducted to evaluate druggability capacity of mitragynine, a natural indole alkaloid compound, using adsorption, distribution, metabolism...
Published in: | Malaysian Journal of Fundamental and Applied Sciences |
---|---|
Main Author: | Tap F.M.; Zakaria N.H.; Majid F.A.A.; Huq A.K.M.M.; Jamal J.A. |
Format: | Article |
Language: | English |
Published: |
Penerbit UTM Press
2022
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85145931929&doi=10.11113%2fmjfas.v18n6.2637&partnerID=40&md5=99418f1994dd63effbb8b4dd3e3827ce |
Similar Items
-
Molecular Docking of Phytochemicals from M. Charantia Targeting SARS-CoV-2 Main Protease
by: Rozani N.H.A.; Tap F.M.; Majid F.A.A.; Mokhtar N.A.; Khairudin N.B.A.
Published: (2025) -
Virtual screening of bioactive anti-SARS-CoV natural products and identification of 3β,12-diacetoxyabieta-6,8,11,13-tetraene as a potential inhibitor of SARS-CoV-2 virus and its infection related pathways by MD simulation and network pharmacology
by: Huq A.K.M.M.; Roney M.; Imran S.; Khan S.U.; Uddin M.N.; Htar T.T.; Baig A.A.; Bhuiyan M.A.; Zakaria Z.A.; Aluwi M.F.F.M.; Tajuddin S.N.
Published: (2023) -
In silico selection of aptamers against SARS-CoV-2
by: Akmal Shukri, et al.
Published: (2024) -
In silico selection of aptamers against SARS-CoV-2
by: Akmal Shukri A.M.; Wang S.M.; Feng C.; Chia S.L.; Mohd Nawi S.F.A.; Citartan M.
Published: (2024) -
The SARS-CoV-2 Variants and their Impacts
by: Shukri A.M.A.; Wang S.M.; Chia S.L.; Nawi S.F.A.M.
Published: (2022)